Heart failure in Europe: Guideline-directed medical therapy use and decision making in chronic and acute, pre-existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction - the ESC EORP Heart Failure III Registry.
Lars H LundMaria Generosa Crespo-LeiroCécile LarocheDiana ZaliaduonyteAly M SaadCandida FonsecaJelena ČelutkienėMarija ZdravkovicAgata M Bielecka-DabrowaPiergiuseppe AgostoniRobert G XuerebKseniya V NeronovaMalgorzata LelonekYuksel CavusogluBarnabas GellenMagdy AbdelhamidNaima HammoudiStefan D AnkerOvidiu ChioncelGerasimos FilippatosMitja LainscakTheresa A McDonaghAlexandre MebazaaMassimo PiepoliFrank RuschitzkaPetar M SeferovićGianluigi SavareseMarco MetraGiuseppe M C RosanoAldo P Maggioninull nullPublished in: European journal of heart failure (2024)
Use and initiation of GDMT was high in cardiology centres in Europe, compared to previous reports from cohorts and registries including more primary care and general medicine and regions more local or outside of Europe and ESC-affiliated countries.